| abstract |
The present disclosure describes methods of treating diseases and conditions of the central and peripheral nervous system by stimulating or enhancing neurogenesis. The disclosure includes agents that modulate muscarinic receptors, alone or in other ways (eg, through inhibition of acetylcholinesterase (AChE) activity) to stimulate or activate the formation of new neurons. Compositions and methods used in combination with neurogenic agents are included. [Selection] Figure 1 |